Protein remodelling of the heart in NO-deficient hypertension: The effect of captopril

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 12, 1997, Pages 3365-3374

  Pecháňová, Ol'ga ^b   Bernátová, Iveta ^c   Pelouch, Václav ^a   Šimko, Fedor ^c  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c NONE

Author keywords

Captopril; Collagenous proteins; DNA; Hypertension; L NAME; Left ventricular hypertrophy; Myofibrillar proteins; NO synthase; RNA

Indexed keywords

ARGININE METHYL ESTER; CAPTOPRIL; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYPROLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT;

ANIMALIA;

EID: 0031459181     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0566     Document Type: Article

References (41)

1. AMRANI M, ONSHEA J, ALLEN NJ, HARDING SE, JAYAKUMAR J, PEPPER JR, MONCADA S, YACOUB MH, 1992. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol 456: 681-687.
2. BABAL P, PECHÁŇOVÁ O, BERNÁTOVÁ ŠTVRTINA S, 1997. Chronic inhibition of NO synthesis produces myocardial flbrosis and vascular medial hyperplasia. Histol Histopathol 12: 623-629.
3. BASS A, SAMÁNEK M, OST'ADAL B, HUČIN B, STEJSKALOVÁ M, PELOUCH V, 1988. Differences between atrial and ventricular energy supplying enzymes in children. J Appl Cardiol 78: 685-694.
4. BERNATOVÁ I, PECHÁŇOVÁ O, ŠIMKO F, 1996. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol Res 45: 311-316.
5. BREDT DS, SNYDER SH, 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685.
6. BROWN GC, 1995. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369: 136-139.
7. CHOMCZYNSKI P, SACCHI N, 1987. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 162: 156-159.
8. CHU A, LIN CC, CHAMBERS DE, KUEHL WD, PALMER RMJ, MONCADA S, COBB FR, 1991. Effects of inhibition of nitric oxide formation on basal tone and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 87: 1964-1968.
9. COOKLIN M, WALLIS WRJ, SHERIDAN DJ, FRY CH, 1997. Changes in cell-to-cell coupling associated with left ventricular hypertrophy. Circ Res 80: 765-771.
10. DELACRETAZ E, HAYOZ D, OSTERHELD MC, GENTON CY, BRUNNER HR, WAEBER B, 1994. Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. Hypertension 23: 967-970.
11. DE MELLO WC, 1994. Is an intracellular reninangiotensin system involved in control of cell communication in heart? J Cardiovasc Pharmacol 23: 640-646.
12. GARG UC, HASSID A, 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscLe cells. J Clin Invest 83: 1774-1777.
13. GEROVÁ M, PECHAŇOVA O, STOEV V, KITTOVÁ M, BERNÁTOVÁ I, BARTA E, 1996. Early changes in protein synthesis in epicardial coronary artery of pressure-overloaded heart. Am J Physiol 270: H685-H691.
14. GIACOMELLI F, ANVERSA P, WIENER J, 1976. Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium. Am J Pathol 84: 111-125.
15. HOLÉCYOVÁ A, TOROK J, BERNATOVA I, PECHÁŇOVÁ O, 1996. Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide deficient hypertension. Physiol Res 45: 317-321.
16. HROPOT M, GROTSCH H, KLAUS E, LANGER KH, LINZ W, WIEMER G, SCHOLKENS BA, 1994. Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency. Naunyn-Schmiedeberg's Arch Pharmacol 350: 646-652.
17. IKEDA U, SHIMADA K, 1994. Nitric oxide release from aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors. Eur J Pharmacol 269: 319-323.
18. JUGGI JS, KOENIG-BERARD E, VAN GILST WH, 1993. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors. Can J Cardiol 9: 336-352.
19. KATTO H, SUZUKI H, TAJIMA S, OGATA Y, TOMINAGA T, SATO A, SATURA T, 1991. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertension 9: 7-22.
20. KOLPAKOV V, GORDON D, KULIK TJ, 1995. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 76: 305-309.
21. KRISTEK F, GEROVA M, DEVAT L, VARGA I, 1996. Remodeling of septal branch of coronary artery and carotide artery in L-NAME treated rats. Physiol Res 45: 329-333.
22. LINZ W, WIEMER G, SCHAPER J, ZIMMERMANN R, NAGASAWAK K, GOHLKE P, UNGER T, SCHOLKENS BA, 1995. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and flbrosis. Mol Cell Biochem 147: 89-97.
23. LOWRY OH, ROSENBROUGH HJ, FARR AL, RANDALL RJ, 1951. Protein measurement with Folin phenol reagent. J Biol Chem 913: 265-275.
24. MORENO H JR, NATHAN LP, COSTA SKP, METZE K, ANTUNES E, ZATZ R, DE NUCCI G, 1995. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur J Pharmacol 287: 93-96.
25. MORGAN HE, BAKER KM, 1991. Cardiac hypertrophy. Mechanical, neural and endocrine dependence. Circulation 83: 13-25.
26. MOTZ W, PLOEGER M, RINGSWANDL G, GOELDER N, GARTHOFF B, KATZDA S, STRAUER BE, 1983. Influence of nifedipine on ventricular function and myocardial hypertrophy in spontaneously hypertensive rats. J Cardiovasc Pharmacol 5: 55-61.
27. PECHÁŇOVÁ O, BERNATOVÁ I, 1996. Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues. Physiol Res 45: 305-309.
28. PECHÁŇOVÁ O, BABAL P, BERNÁTOVÁ I, 1996. Pathologic changes in rat heart after long-term nitric oxide synthase inhibition. In: Moncada S, Stamler J, Gross S, Higgs EA (eds). The biology of nitric oxide. Part 5. London: Portland press, 263.
29. PELOUCH V, 1995. Molecular aspects of regulation of cardiac contraction. Physiol Res 44; 53-61.
30. PELOUCH V, MILEROVA M, OŠT'ÁDAL B, ŠAMÁNEK M, HUČÍN B, 1993. Protein profiling of human atrial and ventricular musculature: the effect of normoxaemia and hypoxaemia in congenital heart diseases. Physiol Res 42: 235-242.
31. PELOUCH V, DIXON IMC, SETHI R, DHALLA NS, 1994. Role of extracellular matrix proteins in heart function. Mol Cell Biochem 4:101-120.
32. PELOUCH V, KOLÁŔ F, KHUCHUA ZA, ELIZAROVA GV, MILEROVA M, OST'ADAL B, SAKS V, 1996. Cardiac phosphocreatine deficiency induced by GPA during postnatal development in rat. Mol Cell Biochem 163/ 164: 67-76.
33. RAMACHANDRAN LK, FRAENKEL-CONRAT H, 1958. The estimation of protein content in RNA. Arch Biochem 74: 224-228.
34. RIBEIRO MO, ANTUNES E, DE NUCCI G, LOVISOLO SM, ZATZ R, 1992. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303.
35. SAMBROOK J, FRITSCH EF, MANIATIS T, 1989. Isolation of DNA from mammalian cells. In: Ford N (ed). Molecular cloning. A laboratory manual. Second edition. New York: Cold Spring Harbor Laboratory Press, 9.16-9.19.
36. SIGUSCH HH, CAMPBELL SE, WEBER KT, 1996. Angiotensin II induced myocardial fibrosis in rats: role of nitric oxide, prostaglandin and bradykinin. Cardiovasc Res 4: 546-554.
37. ŠIMKO F, 1996. Left ventricular hypertrophy regression as a process with variable biological implications. Can J Cardiol 12: 507-513.
38. SLÁDEK T, GEROVÁ M, ZNOJIL V, DEVAT L, 1996. Morphometric characteristic of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol Res 45: 335-338.
39. TÖROK J, GEROVÁ M, 1996. Vascular responses after long-term inhibition of nitric oxide synthesis in newborn dogs. Physiol Res 45: 323-328.
40. XIE YW, SHEN W, ZHAO G, XU X, WOLIN MS, HINTZE TH, 1996. Role of endothelium derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res 3: 381-387.
41. ZIMMER HG, GERDES M, LORTET S, MALL G, 1990. Changes in heart function and cardiac cell size in rats with chronic myocardial infarction. J Mol Cell Cardiol 22: 1231-1243.